WHO ICTRP trial
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED,;2-WAY CROSS-OVER…
NL-OMON41903 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON41903 |
|---|---|
| Public title | A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED,;2-WAY CROSS-OVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF;CHF 5259 (GLYCOPYRROLATE BROMIDE) pMDI ON TOP OF QVAR® pMDI;FOR THE TREATMENT OF PATIENTS WITH UNCONTROLLED ASTHMA;ON LOW-MEDIUM DOSE OF INHALED CORTICOSTEROIDS |
| Scientific title | A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED,;2-WAY CROSS-OVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF;CHF 5259 (GLYCOPYRROLATE BROMIDE) pMDI ON TOP OF QVAR® pMDI;FOR THE TREATMENT OF PATIENTS WITH UNCONTROLLED ASTHMA;ON LOW-MEDIUM DOSE OF INHALED CORTICOSTEROIDS - ELITRA |
| Primary sponsor | CROMSOURCE |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | asthma;10038716;asthma |
| Interventions | The study will comprise 2 treatment groups: * CHF 5259 (50 µg daily dose); * the comparator placebo. All previous treatments shall be stopped after visit 1 in accordance with the non-permitted concomitant medications list. This visit will… |
| Registration date | Mar 2, 2015 |
| Target size | 8 |
| Secondary IDs | 2014-001442-16;NL50049.060.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: